First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(20 sites)

China

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Binzhou Medical University Hospital, Binzhou, Shandong

Shengli Oilfield Central Hospital, Dongying, Shandong

Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong

Shandong Provincial Third Hospital, Jinan, Shandong

Shandong Univerisity Qilu Hospital, Jinan, Shandong

Jinan Third People's Hospital, Jinan, Shandong

Affiliated Hospital of Jining Medical College, Jining, Shandong

Liaocheng People's Hospital, Liaocheng, Shandong

Linyi Cancer Hospital, Linyi, Shandong

Qilu Hospital of Shandong University(Qingdao), Qingdao, Shandong

The Affiliated Hospital of Qingdao University, Qingdao, Shandong

Taian City Central Hospital, Taian, Shandong

The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong

Tengzhou Central People's Hospital, Tengzhou, Shandong

Weifang Hospital of Traditional Chinese Medicine, Weifang, Shandong

Yantai Yuhuangding Hospital, Yantai, Shandong

Yantaishan Hospital, Yantai, Shandong

Zibo Central Hospital, Zibo, Shandong

Zibo First People's Hospital, Zibo, Shandong